Short Interest in BioNxt Solutions Inc. (OTCMKTS:BNXTF) Expands By 156.1%

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 10,500 shares, a growth of 156.1% from the January 31st total of 4,100 shares. Based on an average trading volume of 32,100 shares, the days-to-cover ratio is currently 0.3 days.

BioNxt Solutions Stock Performance

BioNxt Solutions stock traded up $0.01 during midday trading on Friday, reaching $0.35. 200 shares of the company were exchanged, compared to its average volume of 10,361. The firm’s 50-day simple moving average is $0.29 and its 200-day simple moving average is $0.22. BioNxt Solutions has a 1 year low of $0.11 and a 1 year high of $0.49. The company has a market capitalization of $39.66 million, a price-to-earnings ratio of -8.74 and a beta of 0.69.

BioNxt Solutions (OTCMKTS:BNXTF) last issued its quarterly earnings results on Friday, November 29th. The company reported ($0.01) EPS for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.